Advanced Analytical Solutions for Biopharma Development
Built on 20+ years and $40M of pioneering research, ImmPro is the industry leader in top-down proteomics solutions for biopharmaceutical development. Using our proprietary ProteoSight™ platform, we provide the most comprehensive, single-particle analysis of proteins available — delivering insights that conventional methods miss.
-
Gene Therapy Vector Characterization
Quantify AAV capsid heterogeneity to ensure gene therapy quality and regulatory readiness.
-
Intact Proteoform Characterization
Resolve complex protein heterogeneity to validate mechanisms of action and discover biomarkers.
-
Disease-Specific Biomarker Assays
Sensitive detection of disease-relevant proteoforms in neurodegeneration, oncology, and cardiometabolic disease.
-
Custom Biomarker Development
Develop targeted or discovery-based biomarkers to guide development and patient selection.
Powered by ProteoSight™
All services are delivered through ProteoSight, our proprietary single-particle, top-down proteomics platform built on Individual Ion Mass Spectrometry (I2MS). This approach enables direct, high-resolution measurement of intact biomolecules, setting a new standard for precision in biopharma analytics.
